Recently, much interest has been devoted on surface plasmon resonance (SPR) biosensors that are used for evaluation of binding affinity as real-time in clinical and research laboratories.^[@R1]^ The basis of the SPR technique is the changes in the interfacial refractive index of a sensor surface due to the high-affinity interaction between an immobilized biomolecule and its biospecific analyte in solution.^[@R2]^ SPR provides the evaluation of the analyte-immobilized ligand interaction as well as antigen--antibody (Ag-Ab) interaction without any needs for further chemical or biological markers. To acquire a detectable signal in an enzyme-linked immunosorbent assay (ELISA), Abs need to be labeled while SPR permits direct detection in real-time without any labels or additional steps.^[@R1],[@R3]^

Monitoring of immunoresponses by SPR biosensor can be acquired by either use of designated Ag or Ab as ligands. The use of Abs as ligands is favored for analytes with a molecular weight over 1000 Da. Therefore, the immobilized Ab molecules onto the sensor surface may recognize its complementary Ag molecules in a simple, fast and direct way.^[@R1]^ The response of SPR is directly related to the mass changes on the sensor surface. Hence, usually the smaller Ags are immobilized and the larger Abs are present as soluble analytes, through which the Ag--Ab interaction can be investigated.^[@R4]^

There are some tips that should be considered before ligand immobilization: (i) molecular weight, (ii) reactive group, (iii) pH and buffer types, (iv) purity and availability, and (v) control molecule. We discuss some of these hints in details in the following context.

\(i\) Smaller molecules can change refractive index lower than the larger molecules. Thus, researchers usually immobilize small ligands to obtain high signals when large analytes are bounded.

\(ii\) Reactive groups are important to assure covalent coupling to the sensor surface, thus, ligands should contain reactive groups such as -NH~2~, -SH or, -COOH for capturing proteins and oligonucleotides. Streptavidin-biotin capturing methods are also used.

\(iii\) Buffer composition and pH influence analyte binding to the ligand. The typical buffers that are used in SPR experiments are HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) or PBS (Phosphate buffered saline) at concentration of 10 mM and pH 7.4.

\(iv\) The purest interactants are usually applied as the ligand while more available compounds should be used as the analyte.

\(v\) To confirm the successful ligand immobilization, its availability in its proper conformation must be assured.^[@R5]^

Kinetic parameters give information about the rate of complex formation between two molecules (A and B). Association rate constant (k~a~) is indicative of AB number formed per second and dissociation rate constant (k~d~) is demonstrative of complexes fraction which decay per second.

Real-time monitoring of the binding response (i.e., response unit) has been shown in [Fig. 1](#F1){ref-type="fig"}, which presents a way to evaluate binding kinetics.
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Different molecules can have the same affinity to the target but different kinetics. Affinity shows that how much complex is formed at steady state or equilibrium (when association is balanced with dissociation). Affinity unit depends on equilibrium dissociation constant (K~D~) and low values of K~D~ indicate a high tendency of association between two materials that can be calculated through the equation (Eq.) 1^[@R6]^:

$$K_{D} = \frac{k_{d}}{k_{a}}$$

Based on the equilibrium described by equation 2.

$$A + B\underset{k_{d}}{\overset{k_{a}}{\rightleftharpoons}}AB$$

Finally, it is noteworthy that SPR is a useful tool for the direct measurement of affinity between small molecules. Not only steady state but also kinetics of the binding process can be efficiently calculated through SPR real-time and label free measurements.
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